KB Financial Group, Inc. vs TransMedics Group Inc — how do they compare? KB Financial Group, Inc. trades at $118.06 (market cap $41.21B), while TransMedics Group Inc trades at $86.5 (market cap $3.10B). The key difference: KB Financial Group, Inc. is far larger — about 13.3× TransMedics Group Inc's market cap, and KB Financial Group, Inc. pays a 2.67% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| KB | TMDX | |
|---|---|---|
Market Cap | $41.21B | $3.10B |
Sector | Financials | Technology |
52-Week High | $124.01 | $150.42 |
52-Week Low | $77.50 | $61.99 |
Dividend Yield | 2.67% | — |
Enterprise Value | — | $3.49B |
Signals from Pluang's Aura AI — not financial advice
KB Financial Group (KB) trades at $118.00, down 2.26% today, with a bullish technical signal from moving averages. The stock shows strong fundamental performance with consistent earnings beats, 27.82% net income margin, and attractive valuation at P/E of 10.36 and P/B of 0.98. Recent news highlights momentum potential and diversification into non-banking segments, which now contribute 43% of earnings.
Outlook remains positive with earnings growth and shareholder returns as key catalysts, though risks include volatile operating environment and heavy investing cash outflows. Analyst consensus leans cautious with 67% hold ratings, suggesting potential upside requires continued execution on diversification and fee income growth.
No Aura AI signal available yet.
Trailing returns across standard periods
KB Financial is the parent company of KB Kookmin Bank, Korea's largest commercial bank, with a 13.1% share of loans as of 2021. Its predecessor banks were established in the 1960s as government policy banks and privatized in the 1990s. Its credit card subsidiary KB Kookmin Card is the number-three player behind Shinhan Card and Samsung Card. KB has in recent years expanded its nonbank business by buying LIG Insurance and Hyundai Securities, making KB a top-five player in nonlife insurance and in securities, and most recently by buying Prudential Life Insurance Korea. It also has KB Capital, which provides leasing and installment finance.
Read more on KB →TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →